Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG33504

KATNA1 Knockout HT29 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

KATNA1 Knockout HT29 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population of human colorectal adenocarcinoma cells with disrupted KATNA1 gene function. KATNA1 encodes the catalytic p60 subunit of katanin, a microtubule-severing ATPase activated by CDK1 and Aurora A kinases and essential for mitotic spindle dynamics through its interaction with KATNB1 and tubulin. This polyclonal knockout model enables investigation of microtubule cytoskeleton organization, mitotic progression, and migration in colorectal cancer research. Key applications include immunofluorescence analysis of spindle morphology, cell cycle profiling, and functional migration/invasion assays, making it a valuable tool for studying katanin-dependent mechanisms and anti-mitotic therapeutic targets.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HT29

    Gene Name

    KATNA1

    Gene Identifier

    NCBI Gene ID 11104

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    McCoy's 5A

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The KATNA1 Knockout HT29 Polyclonal Cells product provides a CRISPR/Cas9-mediated gene-disrupted polyclonal cell population derived from the HT29 human colorectal adenocarcinoma line, targeting the KATNA1 locus. This polyclonal knockout model is generated without single-cell cloning, preserving a heterogeneous pool of edited alleles that collectively ablate KATNA1 function. The product is designed for loss-of-function studies investigating microtubule-severing ATPase activity in an intestinal epithelial context, enabling robust interrogation of mitotic spindle regulation and cytoskeletal dynamics without clonal selection bias.

HT29 cells are an adherent epithelial line isolated from a human colorectal adenocarcinoma, widely employed as a model for colorectal cancer biology. These cells retain characteristic epithelial morphology and harbor mutations in key oncogenic and tumor-suppressor pathways, including APC and TP53, making them a relevant system for studying transformation-associated processes. Their adherent growth and well-differentiated features facilitate high-resolution imaging of subcellular structures, such as the mitotic spindle and microtubule networks, and they support quantification of proliferation, migration, and invasion in 2D and 3D culture formats.

KATNA1 encodes the p60 catalytic subunit of the heterodimeric microtubule-severing AAA ATPase katanin. Katanin activity is regulated by phosphorylation through CDK1 kinase and Aurora A kinase, especially during mitotic entry, and is essential for severing microtubules into shorter fragments. KATNA1 forms a functional complex with the regulatory p80 subunit KATNB1, and this complex directly interacts with tubulin heterodimers and microtubule-associated proteins on spindle microtubules. Active katanin promotes microtubule depolymerization and contributes to mitotic spindle turnover, impacting spindle assembly, chromosome segregation, and ciliogenesis. Disruption of KATNA1 therefore compromises the controlled severing required for dynamic microtubule remodeling.

In HT29 colorectal cancer cells, loss of KATNA1-mediated microtubule severing impairs mitotic spindle organization and dynamics, leading to defects in chromosome alignment and segregation, prolonged mitosis, and reduced proliferative capacity. Additionally, microtubule network alterations may hinder directed cell migration and invasion, processes central to metastatic progression. This knockout model is therefore highly relevant for dissecting the contribution of microtubule severing to colorectal tumor cell behavior and for evaluating katanin as a therapeutic vulnerability in cancer.

Researchers can utilize this product for mechanistic studies using immunofluorescence microscopy to visualize spindle defects and acetylated tubulin stabilization, western blotting to confirm KATNA1 loss and downstream tubulin modification, flow cytometry for cell cycle arrest analysis, and colony formation or migration assays to assess tumorigenic phenotypes. These applications support investigation of microtubule-severing dynamics in mitosis, katanin-dependent regulation of intestinal epithelial division, and screening of anti-mitotic compounds targeting katanin function. For further details or to discuss custom applications, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)